Cargando…
Predict New Therapeutic Drugs for Hepatocellular Carcinoma Based on Gene Mutation and Expression
Hepatocellular carcinoma (HCC) is the fourth most common primary liver tumor and is an important medical problem worldwide. However, the use of current therapies for HCC is no possible to be cured, and despite numerous attempts and clinical trials, there are not so many approved targeted treatments...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6997129/ https://www.ncbi.nlm.nih.gov/pubmed/32047745 http://dx.doi.org/10.3389/fbioe.2020.00008 |